Heartbeam Valuation
| BEAT Stock | USD 2.74 0.31 12.76% |
Based on Macroaxis valuation methodology, the firm appears to be undervalued. Heartbeam retains a regular Real Value of $3.53 per share. The prevalent price of the firm is $2.74. Our model calculates the value of Heartbeam from evaluating the firm fundamentals such as return on asset of -2.72, and Return On Equity of -7.92 as well as inspecting its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Heartbeam's price fluctuation is extremely dangerous at this time. Calculation of the real value of Heartbeam is based on 3 months time horizon. Increasing Heartbeam's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Heartbeam's intrinsic value may or may not be the same as its current market price of 2.74, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 2.74 | Real 3.53 | Hype 2.87 | Naive 1.61 |
The intrinsic value of Heartbeam's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Heartbeam's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Heartbeam helps investors to forecast how Heartbeam stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Heartbeam more accurately as focusing exclusively on Heartbeam's fundamentals will not take into account other important factors: Heartbeam Total Value Analysis
Heartbeam is currently forecasted to have valuation of 81.84 M with market capitalization of 83.7 M, debt of 1.62 M, and cash on hands of 9.27 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Heartbeam fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
81.84 M | 83.7 M | 1.62 M | 9.27 M |
Heartbeam Asset Utilization
One of the ways to look at asset utilization of Heartbeam is to check how much profit was generated for every dollar of assets it reports. Heartbeam retains a negative application of resources of -2.72 (percent), losing $0.0272 for each dollar of resources held by the firm. Unsuccessful asset utilization attests that the company is being less effective with each dollar of resources it retains. Simply put, asset utilization of Heartbeam shows how unproductive it operates for each dollar spent on its resources.Heartbeam Ownership Allocation
Heartbeam has a total of 34.44 Million outstanding shares. Heartbeam secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Heartbeam Profitability Analysis
Net Loss for the year was (19.45 M) with profit before overhead, payroll, taxes, and interest of 0.About Heartbeam Valuation
The stock valuation mechanism determines Heartbeam's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Heartbeam based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Heartbeam. We calculate exposure to Heartbeam's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Heartbeam's related companies.HeartBeam, Inc., a medical technology company, primarily focuses on telemedicine solutions for the detection and monitoring of cardiac disease outside a healthcare facility setting. The company was incorporated in 2015 and is headquartered in Santa Clara, California. Heartbeam operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 5 people.
Additional Tools for Heartbeam Stock Analysis
When running Heartbeam's price analysis, check to measure Heartbeam's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heartbeam is operating at the current time. Most of Heartbeam's value examination focuses on studying past and present price action to predict the probability of Heartbeam's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heartbeam's price. Additionally, you may evaluate how the addition of Heartbeam to your portfolios can decrease your overall portfolio volatility.